<bill session="105" type="h" number="4683" updated="2013-07-14T18:51:07-04:00">
  <state datetime="1998-10-02">REFERRED</state>
  <status>
    <introduced datetime="1998-10-02"/>
  </status>
  <introduced datetime="1998-10-02"/>
  <titles>
    <title as="introduced" type="short">Women's Health Research and Prevention Amendments of 1998</title>
    <title as="introduced" type="official">To amend the Public Health Service Act to revise and extend certain programs with respect to women's health research and prevention activities at the National Institutes of Health and the Centers for Disease Control and Prevention.</title>
  </titles>
  <sponsor id="400028"/>
  <cosponsors>
    <cosponsor id="400018" joined="1998-10-02"/>
    <cosponsor id="400570" joined="1998-10-02"/>
    <cosponsor id="400571" joined="1998-10-02"/>
    <cosponsor id="400050" joined="1998-10-02"/>
    <cosponsor id="400054" joined="1998-10-02"/>
    <cosponsor id="400099" joined="1998-10-05"/>
    <cosponsor id="400101" joined="1998-10-05"/>
    <cosponsor id="400106" joined="1998-10-07"/>
    <cosponsor id="400110" joined="1998-10-02"/>
    <cosponsor id="400117" joined="1998-10-10"/>
    <cosponsor id="400582" joined="1998-10-05"/>
    <cosponsor id="400517" joined="1998-10-07"/>
    <cosponsor id="404587" joined="1998-10-02"/>
    <cosponsor id="400160" joined="1998-10-02"/>
    <cosponsor id="400161" joined="1998-10-02"/>
    <cosponsor id="400165" joined="1998-10-15"/>
    <cosponsor id="400169" joined="1998-10-02"/>
    <cosponsor id="400594" joined="1998-10-02"/>
    <cosponsor id="400524" joined="1998-10-13"/>
    <cosponsor id="400604" joined="1998-10-02"/>
    <cosponsor id="400325" joined="1998-10-12"/>
    <cosponsor id="400605" joined="1998-10-02"/>
    <cosponsor id="400357" joined="1998-10-09"/>
    <cosponsor id="400366" joined="1998-10-13"/>
    <cosponsor id="400371" joined="1998-10-09"/>
    <cosponsor id="400373" joined="1998-10-06"/>
    <cosponsor id="400378" joined="1998-10-09"/>
    <cosponsor id="400388" joined="1998-10-02"/>
    <cosponsor id="400390" joined="1998-10-02"/>
    <cosponsor id="400422" joined="1998-10-12"/>
    <cosponsor id="400425" joined="1998-10-02"/>
    <cosponsor id="400434" joined="1998-10-10"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1998-10-02">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1998-10-05">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
    <action datetime="1998-10-05">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1901"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="105" type="s" number="1722"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Academic medical centers"/>
    <term name="Authorization"/>
    <term name="Autoimmune diseases"/>
    <term name="Black women"/>
    <term name="Bone diseases"/>
    <term name="Breast cancer"/>
    <term name="Cancer"/>
    <term name="Cancer research"/>
    <term name="Carcinogens"/>
    <term name="Cardiovascular diseases"/>
    <term name="Cervical cancer"/>
    <term name="Cholesterol"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Disabled"/>
    <term name="Drug abuse"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Education"/>
    <term name="Epidemiology"/>
    <term name="Executive reorganization"/>
    <term name="Exercise"/>
    <term name="Federal advisory bodies"/>
    <term name="Federal aid to health facilities"/>
    <term name="Federal aid to medical education"/>
    <term name="Federal aid to medical research"/>
    <term name="Geriatrics"/>
    <term name="Government operations and politics"/>
    <term name="Government publicity"/>
    <term name="Gynecology"/>
    <term name="Health education"/>
    <term name="Heart diseases"/>
    <term name="Higher education"/>
    <term name="Hypertension"/>
    <term name="Immunology"/>
    <term name="Medical education"/>
    <term name="Medical research"/>
    <term name="Medical screening"/>
    <term name="Medical statistics"/>
    <term name="Minorities"/>
    <term name="Minority health"/>
    <term name="Minority women"/>
    <term name="Nonprofit organizations"/>
    <term name="Obesity"/>
    <term name="Older women"/>
    <term name="Osteoporosis"/>
    <term name="Ovarian cancer"/>
    <term name="Pregnant women"/>
    <term name="Preventive medicine"/>
    <term name="Rehabilitation of the disabled"/>
    <term name="Research centers"/>
    <term name="Science, technology, communications"/>
    <term name="Smoking"/>
    <term name="Social welfare"/>
    <term name="Sports and recreation"/>
    <term name="Stroke"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary>10/2/1998--Introduced.
TABLE OF CONTENTS: Title I: Provisions Relating to Women's Health Research at National Institutes of Health Title II: Provisions Relating to Women's Health at Centers for Disease Control and Prevention Women's Health Research and Prevention Amendments of 1998 - Title I: Provisions Relating to Women's Health Research at National Institutes of Health - Amends the Public Health Service Act to extend the authorization of appropriations for programs regarding diethylstilbestrol (DES). Mandates a program of education of health professionals and the public concerning DES. Authorizes appropriations. (Sec. 102) Extends the authorizations of appropriations for: (1) research on osteoporosis, Paget's disease, and related bone disorders; (2) breast cancer programs; and (3) programs on ovarian and other cancers of the reproductive system of women. (Sec. 104) Mandates expansion, intensification, and coordination of research and related activities of the National Heart, Lung, and Blood Institute regarding heart attack, stroke, and other cardiovascular diseases in women. Authorizes appropriations. (Sec. 105) Authorizes appropriations for research into the aging processes of women. (Sec. 106) Requires that the Director of the National Institutes of Health (currently, the Director of the Office of Research on Women's Health) appoint members of the Advisory Committee on Women's Health. Title II: Provisions Relating to Women's Health at Centers for Disease Control and Prevention - Adds the provision of support services such as case management to the purposes of breast and cervical cancer programs (authorized under current provisions). Extends the authorization of appropriations for the National Center for Health Statistics and the National Program of Cancer Registries. (Sec. 203) Allows certain breast and cervical cancer programs to be carried out through grants to public and nonprofit private entities and contracts with public or private entities (currently, through grants and contracts with public or nonprofit private entities). Allows a State to give priority to a nonprofit entity over an entity that is not a nonprofit if the quality of the entities' applications are equivalent. Extends authorizations of appropriations for various preventive health measures relating to breast and cervical cancers. (Sec. 204) Extends the authorizations of appropriations for: (1) centers for research and demonstration regarding health promotion and disease prevention; and (2) community projects to coordinate intervention and prevention of domestic violence.</summary>
</bill>
